Jeremy Grantham's BRKR Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 281,239 shares of Bruker Corporation (BRKR) worth $10.16 M, representing 0.03% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in BRKR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 388,272 shares. Largest reduction occurred in Q2 2024, reducing 265,583 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Bruker Corporation (BRKR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bruker Corporation (BRKR) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +3,473 | Add 1.25% | 281,239 | $36.12 |
| Q4 2025 | -192,935 | Reduce 40.99% | 277,766 | $47.11 |
| Q3 2025 | +4,394 | Add 0.94% | 470,701 | $32.49 |
| Q2 2025 | +78,035 | Add 20.10% | 466,307 | $41.20 |
| Q1 2025 | +388,272 | New Buy | 388,272 | $41.74 |
| Q2 2024 | -265,583 | Sold Out | 0 | $0.00 |
| Q1 2024 | +60,824 | Add 29.71% | 265,583 | $93.94 |
| Q4 2023 | +58,946 | Add 40.43% | 204,759 | $73.48 |
| Q3 2023 | +28,062 | Add 23.83% | 145,813 | $62.30 |
| Q1 2023 | +44,255 | Add 60.21% | 117,751 | $78.84 |
| Q4 2022 | -29,383 | Reduce 28.56% | 73,496 | $68.35 |
| Q3 2022 | +102,879 | New Buy | 102,879 | $53.06 |
| Q2 2020 | -24,500 | Sold Out | 0 | $0.00 |
| Q1 2020 | -225 | Reduce 0.91% | 24,500 | $35.88 |
| Q4 2019 | -17,002 | Reduce 40.75% | 24,725 | $50.96 |
| Q3 2019 | -17,100 | Reduce 29.07% | 41,727 | $43.93 |
| Q2 2019 | -17,370 | Reduce 22.80% | 58,827 | $49.94 |
| Q1 2019 | -11,200 | Reduce 12.82% | 76,197 | $38.44 |
| Q4 2018 | -7,500 | Reduce 7.90% | 87,397 | $29.77 |
| Q3 2018 | -7,200 | Reduce 7.05% | 94,897 | $33.45 |
| Q2 2018 | +12,797 | Add 14.33% | 102,097 | $29.04 |
| Q1 2018 | +69,900 | Add 360.31% | 89,300 | $29.92 |
| Q4 2017 | +8,800 | Add 83.02% | 19,400 | $34.33 |
| Q3 2017 | +10,600 | New Buy | 10,600 | $29.72 |
Jeremy Grantham's Bruker Corporation Investment FAQs
Jeremy Grantham first purchased Bruker Corporation (BRKR) in Q3 2017, acquiring 10,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Bruker Corporation (BRKR) for 25 quarters since Q3 2017.
Jeremy Grantham's largest addition to Bruker Corporation (BRKR) was in Q1 2025, adding 388,272 shares worth $16.21 M.
According to the latest 13F filing for Q1 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 281,239 shares of Bruker Corporation (BRKR), valued at approximately $10.16 M.
As of the Q1 2026 filing, Bruker Corporation (BRKR) represents approximately 0.03% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Bruker Corporation (BRKR) was 470,701 shares, as reported at the end of Q3 2025.